Please login to the form below

Not currently logged in
Email:
Password:

Death leads to recall of batch of Takeda's Rienso in Switzerland

Marketing partner Amag also reports three other hypersensitivity reactions

Death leads to recall of batch of Takeda's Rienso in SwitzerlandTakeda has recalled a batch of its anaemia medicine Rienso (ferumoxytol) in Switzerland following four reports of hypersensitivity reactions, including one death.

Amag Pharmaceuticals – Takeda's marketing partner in the country – announced the recall in a regulatory filing on Tuesday, in which it said “[t]he batch was only distributed to and sold in Switzerland and the recall is limited to the specific batch and specifically Switzerland”.

Further details of the fatality or other reactions were not given, although the filing did say IV irons, such as Rienso, may cause serious hypersensitivity reactions, including anaphylactic reaction.

As reported by Reuters, Amag's shares were down about 5 per cent following the recall announcement.

Both Amag and Takeda are now investigating the Swiss batch of Rienso, while the introduction of new batches will depend on approval by Swiss health regulator Swissmedic.

Swissmedic also confirmed the batch was distributed solely in Switzerland, and the recall would not affect other countries.

Rienso is sold as Feraheme in the US and Canada, where Takeda is the exclusive distributor.

This isn't the first recall that has affected Takeda this year, with the company forced to issue a US withdrawal of Omontys (peginesatide) – a medicine to treat anaemia caused by chronic kidney disease – after several deaths were reported due to serious hypersensitivity reactions within 30 minutes following the first intravenous dose of treatment.

Takeda was also given a six-month suspension from its duties as vice president of the Japan Pharmaceutical Manufacturers Association (JPMA) as a result of a labelling error for vitamin supplement Alinamin F5, which led to a recall of a batch of the product.

claimtoken-519e03df40561

23rd May 2013

From: Sales, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...